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The origins and developmental mechanisms of
coronary arteries are incompletely understood.
We show here by fate mapping, clonal analysis,
and immunohistochemistry that endocardial cells
generate the endothelium of coronary arteries. Dye
tracking, live imaging, and tissue transplantation
also revealed that ventricular endocardial cells are
not terminally differentiated; instead, they are angio-
genic and form coronary endothelial networks.
Myocardial Vegf-a or endocardial Vegfr-2 deletion in-
hibited coronary angiogenesis and arterial formation
by ventricular endocardial cells. In contrast, lineage
and knockout studies showed that endocardial cells
make a small contribution to the coronary veins, the
formation of which is independent of myocardial-
to-endocardial Vegf signaling. Thus, contrary to the
current view of a common source for the coronary
vessels, our findings indicate that the coronary
arteries and veins have distinct origins and are
formed by different mechanisms. This information
may help develop better cell therapies for coronary
artery disease.
INTRODUCTION
Despite the medical importance of coronary arteries, their
embryonic origins and developmental mechanisms remain
unclear. These arteries are the loci for coronary artery
disease, the most widespread disease in western societies.CElucidating mechanisms of coronary artery formation may help
recapitulate this developmental process for coronary artery
regeneration.
Coronary arteries have three tissue layers: the inner layer of
endothelium, the middle layer of smooth muscle cells, and the
outer layer of fibroblasts. The endothelium is the first layer
formed during coronary artery formation. Primitive coronary
vessels (or coronary plexuses) consist of one endothelial cell
layer. The plexuses then recruit smooth muscle cells and fibro-
blasts to assemble mature arteries. Endothelium is also the
first site where coronary artery disease occurs in adults. Thus,
identifying the cellular origins of coronary endothelium is essen-
tial to elucidate mechanisms of coronary artery development
or regeneration.
The heart is made of three major tissue layers: the endocar-
dium, myocardium, and epicardium. The myocardium is the
central layer, and the coronary vasculature forms within this
layer during development. The epicardium is the outermost
epithelial layer of the heart; it is derived from the proepicardium
outside the heart (Komiyama et al., 1987; Vira´gh and Challice,
1981). Studies have shown that epicardial cells generate coro-
nary vascular smooth muscle cells (Cai et al., 2008; Dettman
et al., 1998; Mikawa and Fischman, 1992; Mikawa and Gourdie,
1996; Vrancken Peeters et al., 1999; Zhou et al., 2008). It is less
clear whether proepicardial/epicardial cells make any significant
contribution to coronary endothelial cells, although some coro-
nary endothelial cells in avian species are derived from proepi-
cardial cells (Mikawa et al., 1992; Pe´rez-Pomares et al., 2002).
Fate-mapping studies inmice have suggested the sinus venosus
as a common origin of the endothelium of coronary arteries
and veins (Red-Horse et al., 2010), and a subset of proepicardial
cells also contributes to some coronary endothelial cells (Katz
et al., 2012).ell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc. 1083
The endocardium is the internal epithelial layer of the heart.
Endocardial cells are one of the earliest endothelial populations
acquired in development, differentiating from multipotent
progenitors in the cardiac field (Misfeldt et al., 2009; Sugi and
Markwald, 1996; Yamashita et al., 2000; Yang et al., 2008).
They form an endocardial tube by vasculogenesis and later
become the endocardium of the heart (Drake and Fleming,
2000). Endothelial cells of coronary vessels arise later in devel-
opment and form coronary vessels in the myocardium (Lavine
and Ornitz, 2009; Luttun and Carmeliet, 2003; Majesky, 2004;
Olivey and Svensson, 2010;Wada et al., 2003). Ventricular endo-
cardial cells have been thought to be terminally differentiated
without a significant role in coronary vessel formation.
Here, we showed that ventricular endocardial cells are a major
origin of coronary artery endothelium. Myocardial Vegf-a to
endocardial Vegfr-2 signaling is required for these cells to
differentiate into coronary endothelium. The information may
have implications for engineering better vessels for coronary
artery regeneration.
RESULTS
Characterization of Nfatc1 Expression during Coronary
Vessel Development
Cardiac endocardial cells comprise a unique endothelial cell
population that expresses Nfatc1 during development, whereas
vascular endothelial cells do not express Nfatc1 (Chang et al.,
2004; de la Pompa et al., 1998; Ranger et al., 1998; Zhou
et al., 2005). In this study, we further characterized Nfatc1
expression in embryonic tissues relative to coronary develop-
ment. We confirmed by in situ hybridization that Nfatc1 tran-
scripts demarcated endocardium at embryonic day (E) 9.5, since
the endothelium of aortic sac, sinus venosus, and the rest of the
peripheral vasculature was negative for Nfatc1 transcripts
(Figures 1A and 1B). Nfatc1 transcripts were not found in the
proepicardium either. At E10.5 Nfatc1 transcripts were similarly
restricted to the endocardium (Figure 1C). Likewise, double
immunostaining of Nfatc1 and Pecam1 (pan-endothelial marker)
revealed that Nfatc1 proteins were confined to the endocardium
(Figure 1D). Neither Nfatc1 transcripts nor proteins were de-
tected in the forming epicardium. Furthermore, coimmunostain-
ing of Nfatc1 and Tbx18 (epicardial marker) (Kraus et al., 2001)
confirmed that epicardial cells did not express Nfatc1 at E11.5
(Figure 1E).
When coronary plexuses developed from E11.5 to E13.5,
Nfatc1 transcripts were downregulated in the ventricular endo-
cardium (data not shown) while Nfatc1 proteins remained in
a subset of endocardial cells (Figures 1F–1H). Neither Nfatc1
transcripts (data not shown) nor Nfatc1 proteins were found
in the endothelium of coronary plexuses (Figures 1G and 1H).
Likewise, the endothelium of developed coronary vessels from
E14.5 to E16.5 did not have detectable Nfatc1 transcripts or
Nfatc1 proteins, which were found only in the valve endocardium
(Figures S1A–S1F available online; Supplemental Information).
These findings showed that Nfatc1 expression is restricted to
the endocardium during coronary development. Nfatc1 is not
expressed in the proepicardium/epicardium, sinus venosus, or
developing coronary vessels.1084 Cell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc.Nfatc1+ Endocardial Precursors Generate Coronary
Plexuses
To study the developmental fate and function of endocardial
cells, we generated a Cre knockin mouse strain, Nfatc1Cre, in
which Cre cDNA with an internal ribosomal entry site was in-
serted downstream of the stop codon of the mouse Nfatc1
(Zhou et al., 2002) (Figure S2A). Nfatc1Cre mice developed nor-
mally and bred to the RCEfsEGFP (Miyoshi et al., 2010; Sousa
et al., 2009) or R26fslz mice (Soriano, 1999). Cre expression
was restricted to the endocardium of Nfatc1Cre embryos; no
expression was seen in the sinus venosus, liver, pharyngeal
arch, proepicardium/epicardium, or myocardium at E9.5–E10.5
(Figure S2B), or developing coronary vessels (data not shown).
The fate of endocardial cells was then tracked by the inherited
expression of enhanced green fluorescent protein (EGFP) or
beta-galactosidase (b-gal hereafter). Nfatc1Cre-mediated EGFP
expression began at E9.0 in the endocardium of Nfatc1Cre;
RCEfsEGFP embryos, and, at E10.5, EGFP expression was limited
to the heart proper ofNfatc1Cre;RCEfsEGFP embryos (Figure S2C).
Sectional examination of E9.5–E10.5 Nfatc1Cre;RCEfslz embryos
confirmed restricted b-gal expression in the endocardium
(Figures S2D and S2E) and in the cushion mesenchyme derived
from endocardial cells (Figures S2F and S2G). Neither Cre
reporter gene was expressed in the proepicardium/epicardium,
myocardium, pharyngeal arch, or liver bud (Figures S2C–S2G).
Although Nfatc1 expression was not found in the sinus venous
endothelium (Figure S2H), Nfatc1Cre-mediated b-gal or EGFP
expression was observed in some sinus venous endothelial
cells at E10.5–E11.5 (Figures S2I–S2J), suggesting that Nfatc1+
endocardial cells contribute to a subset of sinus venous endo-
thelial population.
We then examined the lineage contribution of endocardial
cells to coronary vessels in Nfatc1Cre;R26fslz embryos and found
that cells of the emerging coronary plexuses at E11.5–E13.5
uniformly expressed b-gal (Figure 2). The b-gal+ cells, derived
from the Nfatc1+ precursors at E11.5 (Figure 2A), invaded the
myocardium at E12.5 (Figure 2B) and formed coronary plexuses
throughout the myocardium at E13.5 (Figure 2C). Conversely,
in control Nfatc1lacZ-BAC embryos that expressed b-gal driven
by the Nfatc1 promoter/enhancer (Misfeldt et al., 2009), b-gal
expression (an indicator of the Nfatc1Cre activities) was restricted
to the endocardium and absent in coronary plexuses (Figures
2D–2F). This observation is consistent with the finding that
coronary plexuses do not express Nfatc1 at these stages, thus
further eliminating the possibility of ectopic Cre expression in
coronary plexuses.
To verify the cell identity of the endocardial-derived coronary
cells, we colabeled the EGFP+ descendants of Nfatc1+ endo-
cardial cells with Pecam1 antibodies in Nfatc1Cre;RCEfsEGFP
embryos. We found that most Pecam1-positive cells in the peri-
truncal coronary vessels expressed EGFP at E12.5, whereas
the vessels outside the heart were labeled only by Pecam1
antibodies (Figures 2G–2I). Also, all coronary plexuses arising
at E11.5–E13.5 in the ventricular wall coexpressed Pecam1
and EGFP (Figures S2K–S2M). We then stained E14.5 or E16.5
Nfatc1Cre;RCEfsEGFP heart sections with multiple cardiovascular
markers (Table S1) and found that the EGFP+ descendants of
Nfatc1+ endocardial cells were present in the endothelium of
Figure 1. In Situ Hybridization and Immunochemistry Show thatNfatc1 Expression Is Restricted to the Endocardium during Coronary Plexus
Formation
(A and B) E9.5 heart sections show Nfatc1 transcripts in the endocardium (ec, arrows). Nfatc1 transcript signals separate the positive endocardium from the
negative endothelium of aortic sac (as) and sinus venosus (sv) (arrowheads). Background signals are seen in the proepicardium (pe). a, atrium; oft, outflow tract; v,
ventricle.
(C) E10.5 ventricular sections show Nfatc1 transcripts in the endocardium (arrows) but not epicardium (arrowheads). tb, trabeculae.
(D) E10.5 heart sections coimmunostained with antibodies against Nfatc1 (brown nuclear staining) and Pecam1 (red membrane staining) show Nfatc1 proteins in
the endocardium (arrows) but not epicardium (arrowheads).
(E) E11.5 heart sections show Nfatc1 proteins in the endocardium (arrows) but not in the Tbx18-positive epicardium (arrowheads).
(F–H) E11.5–E13.5 heart sections stained with antibodies against Nfatc1 and Pecam1 show that Nfatc1 proteins are restricted to the endocardium (arrows). They
are not present in the endothelium of coronary plexuses or Pecam1-positive cells in the myocardium (myo, arrowheads) or the mature coronary vessels. Dashed
line separates the trabeculae from the compact wall. ep, epicardium.
Scale bars, 25 mm. See also Figure S1.coronary arteries expressing arterial endothelial markers Dll4
(Figures 2J and S2N), Ephb2, and Jagged1 (data not shown).
We also noted that, although endocardial cells were negative
for von Willebrand factor (vWF), their descendants in coronaryCarteries acquired vWF expression (Figure 2K). Thus, the acquisi-
tion of vWF and loss ofNfatc1 expression in coronary endothelial
cells may serve as makers for endocardial to coronary endothe-
lial differentiation. Further staining of smooth muscle myosinell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc. 1085
Figure 2. Fate-Mapping Analysis Reveals that Nfatc1+ Endocardial Cells Generate Coronary Vascular Endothelium
(A–C) X-gal-stained E11.5–E13.5 heart sections of Nfatc1Cre;R26fslz embryos show that the b-gal-tagged Nfatc1+ endocardial cells reside in the endocardium of
the myocardial wall and trabeculae at E11.5 (A). They begin to invade the myocardium at E12.5 (B, arrowheads) and generate networks of coronary plexuses at
E13.5 (C, arrowheads). The descendants of Nfatc1+ cells are not present in the epicardium and myocardium.
(D–F) X-gal-stained E11.5–E13.5 heart sections of control Nfatc1lacZ-BAC embryos show that the b-gal activities directed by the Nfatc1 promoter/enhancer are
restricted to the endocardium and not present in the myocardium and epicardium. Unlike Nfatc1Cre, Nfatc1lacZ does not label the coronary plexuses.
(G–I) Dual fluorescent sections through ventricular (v) outflow tract (oft) of E12.5 Nfatc1Cre;RCEfsEGFP embryos show the EGFP+ endothelial descendants
of Nfatc1+ endocardial cells in the Pecam1+ coronary plexuses in the peritruncal region (ptv). The peripheral vessels (arrowheads) expressing Pecam1 but not
EGFP are not derived from the Nfatc1+ endocardial cells. Mesenchyme of atrioventricular canal (avc, asterisk), derived from the cushion endocardial cells, is
EGFP positive but Pecam1 negative.
(J and K) Dual fluorescent sections of E14.5 Nfatc1Cre;RCEfsEGFP heart show EGFP+ endothelial descendants of endocardial cells in the Dll4+ or vWF+ endo-
thelium (red) of the main coronary arteries (ca). The trabecular endocardium is negative for vWF.
(L and M) Dual fluorescent sections of E16.5 Nfatc1Cre;RCEfsEGFP heart show EGFP+ endothelial descendants of endocardial cells in the inner layer of the
coronary arteries (ca) surrounded by smooth muscle cells positive for SM-MHC or SM22a.
Scale bars, 25 mm. See also Figure S2.
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heavy chain (SM-MHC) and SM22a showed that the EGFP+
endocardial descendants contributed to the endothelium of
developed coronary arteries, but they did not become vascular
smooth muscle cells of the cognate vessels (Figures 2L and
2M). In contrast to their prominent arterial presence, few
EGFP+ descendants of endocardial cells were found in coronary
veins (Figure S2O). EGFP+ descendants were also absent in
lymphatic vessels (Figure S2P) and did not become cardiomyo-
cytes (Figure S2Q).
We further compared the fate mapping of Nfatc1Cre-marked
endocardial cells in coronary vessels to that of Tie1Cre-labeled
pan-endothelial (arterial and venous) cells (Gustafsson et al.,
2001). Unlike Tie1+ endothelial descendants, which formed
vascular networks on the surface of E14.5 hearts, Nfatc1+ endo-
cardial descendants did not form the networks but contributed
to the intramyocardial vessels (Figures S2R and S2S). Pecam1
staining of E16.5 Nfatc1Cre;RCEfsEGFP hearts confirmed that
Nfatc1+ endocardial descendants contributed to most intra-
myocardial vessels (including the main arteries), with much
less presence in the subepicardial vessels (Figures S2T and
S2U). Coronary arteriograms of E16.5 Nfatc1Cre;RCEfsEGFP
hearts validated that EGFP+ descendants ofNfatc1+ endocardial
cells contributed to the entire coronary artery network, including
the main coronary arteries and their branches, arterioles, and
capillaries (Figures S2V–S2Y).
Quantitative analysis of Nfatc1+ endocardial descendants in
the coronary vessels of E16.5 hearts showed that they contrib-
uted to 72%, 81%, or 37% endothelial population of major
coronary arteries, intramyocardial, or subepicardial vessels,
respectively (Figure S2Z). These findings establish that endo-
cardial cells are a major source of endothelial cells of the
intramyocardial vessels including major coronary arteries and
suggest that the majority of subepicardial vascular endothelium
arises from a different origin.
Clonal Analysis Establishes Spatiotemporal
Differentiation of Endocardial Cells into Coronary
Endothelial Cells
To confirm that the endocardium is a major source of coronary
arterial endothelial cells and determine when endocardial cells
are committed to a coronary endothelial fate, we generated
Nfatc1nrtTA-BAC mice using an Nfatc1-BAC DNA (Figures S3A
and S3B) and bred them with tetO-Cre;RCEfsEGFP or tetO-
Cre;R26fslz mice. When induced with doxycycline (Dox) at
E7.5–E11.5, the tetO-Cre-mediated EGFP expression was found
to mark endocardial cells and their mesenchymal descendants
(Figures S3C–S3F). A limited Dox dose was then applied for
24 hr, at E9.5, E10.5, E11.5, or E12.5 (Figure 3A), to induce
rare recombination events in individual cells in the endocardium
(Figure 3B). The expansion of EGFP+ or b-gal+ single cells were
chased for 1–7 days until E14.5 or E16.5, and the clonality and
coronary location of cell clusters were determined by expression
of the reporters, vascular markers, and histology. We analyzed
39 whole hearts by evaluating serial sections (Table S2; Figures
3C–3H). Single or separated EGFP+ or b-gal + cell clusters were
found in the endothelium of major or small coronary arteries
(Figures 3C–3E), veins (Figure 3F), or capillaries (Figures 3G
and 3H). Some cells near developing arteries exhibited filopodiaC(Figure S3G), suggesting that they were migrating cells. Cell
clusters were also found in heart valves (Figures S3H and S3I).
However, they were not detected in the sinus venosus.
Quantitative analysis of clones showed that over 86% of the
Nfatc1+ endothelial descendants that derived at E9.5–E13.5
were in the intramyocardial vessels at E14.5 or E16.5; the
remainders were in the subepicardial vessels (Figures S4A and
S4B). The endocardial precursors labeled around E11.5 gener-
ated most coronary endothelial cells; their ability to differentiate
into endothelial cells was greatly reduced after E12.5. Consistent
with their predominant presence in the endothelium of intra-
myocardial vessels, the number of Nfatc1+ endothelial descen-
dants found in the main coronary arteries at E14.5 or E16.5
was 13 or 5 times greater than that in themain veins (Figure S4C).
Furthermore, the numbers of labeled endocardial cells across
the 39 analyzed hearts correlated significantly with the numbers
of their sister endothelial cells in both intramyocardial and
subepicardial vessels. However, the correlation between the
endocardial and intramyocardial numbers (Pearson’s correlation
coefficient r = 0.86, p = 4.0 3 1012) was higher than that
between the endocardial and subepicardial numbers (r = 0.59,
p = 8.2 3 105) (Figure S4D).
Thus, clonal analysis suggests that endocardial cells commit
to a coronary endothelial fate right before coronary plexus
formation and supports the conclusion from the Nfatc1Cre
fate mapping that the endocardium is a major source of the
endothelium of intramyocardial vessels and major coronary
arteries.
Ventricular Endocardial Cells Form Coronary Plexuses
by Angiogenesis
To visualize how ventricular endocardial cells generated coro-
nary plexuses, we isolated hearts from E10.5 or E11.5 embryos
and labeled endocardial cells with Red Fluorescent CMTPX. The
ventricles were used in a Matrigel endothelial tube assay. We
found single-labeled endocardial cells that hadmigrated through
the myocardial wall into Matrigel in the presence of Vegf120
(Figures S5A–S5C). When using the red dye to label Nfatc1Cre;
RCEfsEGFP embryonic ventricles, we observed dye-labeled indi-
vidual cells integrated into an endothelial network generated
by EGFP+ descendants of Nfatc1+ ventricular endocardial cells
(Figures 4A–4C).
The angiogenic function of endocardial cells was further
characterized by time-lapse fluorescence live imaging and quan-
tified. Without Vegf120, Nfatc1+ precursors invaded the ventric-
ular wall and sprouted to form endothelial tubes, which then
fused into distinct vessels in the myocardium (Movie S1). With
Vegf120, the Nfatc1+ precursors readily migrated through the
ventricular wall (Movie S2) and underwent angiogenic sprouting
(Figures 4D and 4E). Within 6 days of Vegf120 exposure, the
descendants of Nfatc1+ precursors generated sophisticated
endothelial networks (Figures 4G and 4H). In contrast, angio-
genic sprouting and networking were significantly limited
without Vegf120 (Figures 4F and 4I). Besides Vegf120, other
Vegf-a isoforms such as Vegf164 and Vegf188 were capable
of promoting coronary angiogenesis, whereas Vegf-c, Vegf-d,
Fgf2, and Fgf9 had partial or no effects (data not shown).
These data showed that endocardial cells can develop intoell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc. 1087
Figure 3. Clonal Analysis of Coronary Development Shows the Descendants of Nfatc1+ Endocardial Cells in the Coronary Vascular
Endothelium
(A) A schematic diagram showing clonal analysis of coronary development using the Nfatc1nrtTA;tetO-Cre system induced by doxycycline (Dox).
(B) Heart section of Nfatc1nrtTA;tetO-Cre;RCEfsEGFP E11.5 embryo induced at E10.5 with a limited Dox dose shows single EGFP-labeled cells in the endocardium
(arrowhead).
(C–E) Sections of E16.5 Nfatc1nrtTA;tetO-Cre;RCEfsEGFP heart induced at E9.5 (C) or E10.5 (D and E) show the EGFP+ cell clusters in the large (C and D) or small
coronary arteries (arrows) expressing SM22a.
(F) Sections of E16.5 Nfatc1nrtTA;tetO-Cre;RCEfsEGFP heart induced at E10.5 shows the EGFP+ cell clusters (arrowhead) in the subepicardial vessels alongside
the SM22a+ cells.
(G) Sections of E16.5 Nfatc1nrtTA;tetO-Cre;R26fslz heart induced at E12.5 shows the LacZ-labeled capillary cells (cc) cluster (green; arrows) alongside the
SM22a-expressing small arteries (red).
(H) Sections of E16.5 Nfatc1nrtTA;tetO-Cre;R26fslz heart induced at E11.5 shows the LacZ+ capillary cells cluster (arrows) alongside the Pecam1+ small vessels
(red).
Scale bars, 20 mm. See also Figures S3 and S4 and Table S2.coronary endothelial networks and suggested that Vegf-a is
a major factor involved in coronary plexus formation by ventric-
ular endocardial cells.1088 Cell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc.To further test coronary angiogenesis by ventricular endo-
cardial cells, we conducted quail-to-chick transplantation
experiments in which we isolated ventricular endocardium or
Figure 4. Dye Labeling, Ventricular Explant Culture, and Tissue Transplantation Show that Ventricular Endocardial Cells Form the Vascular
Plexus by Angiogenesis
(A–C) Dye labeling and explant Matrigel cultures using ventricles from E11.5 Nfatc1Cre;RCEfsEGFP hearts (h) show red fluorescent CMTPX-labeled individual
endocardial cells (arrows) that had migrated through the ventricular wall and integrated into an EGFP+ endothelial network upon Vegf120 treatment.
(D–I) Matrigel angiogenesis assays show that Vegf120 significantly promotes transmural migration, sprouting (arrowheads), and endothelial networking
(asterisks) by Nfatc1+ descendants. The error bars represent SD. See also Movies S1 and S2.
(J–L) Images of QH1 antibody stained HH34 quail-chick chimerical heart sliced through the right ventricle at the implanted site show that the QH1+ descendants
of engrafted HH15 quail endocardial cells invade chick myocardium and generate intramyocardial vessels. Quail endocardial cells, implanted at the surface of
the atrioventricular junction of the chick heart (K), generate intensive myocardial vascular networks by angiogenic sprouting and branching (L, arrowheads).
See also Figure S5 and Table S3.
Cell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc. 1089
proepicardium from quail embryonic hearts at the Hamburger
and Hamilton (HH) stage 15 (prior to coronary plexus formation)
and implanted them at the inner curvature of the atrioventricular
junction of HH15 chick embryonic hearts (Figure S5D). Using
the QH1 antibody that labels quail, but not host chick, endothe-
lial cells, we detected the contribution of implanted quail cells
to coronary arteries of chick hearts at HH34 (Figures S5E and
S5F). Quail endocardial cells invaded chick ventricular wall and
developed into an extensive endothelial network in the myo-
cardium (Figures 4J–4L), whereas quail proepicardium largely
generated subepicardial vessels (Table S3; data not shown).
Together, the results from four distinct experimental ap-
proaches (Nfatc1Cre fate mapping, clonal analysis, dye labeling,
and cross-species transplantation) all demonstrate that ventric-
ular endocardial cells generate endothelial cells of coronary
arteries. The endocardial descendants comprise the majority of
endothelial cells in intramyocardial vessels and coronary
arteries. They further show that endocardial cells are not termi-
nally differentiated; they are angiogenic and are activated by
Vegf-a to generate coronary plexuses.
Myocardial Vegf-a Is Required for Coronary
Angiogenesis and Artery Formation
Vegf-a is known to be produced by the developing myocardium
(Giordano et al., 2001; Miquerol et al., 2000; Tomanek et al.,
2006) and required for vasculogenesis and angiogenesis in
development (Carmeliet et al., 1996; Ferrara et al., 1996). There-
fore, we asked if myocardial Vegf-a was necessary in vivo for
endocardial cells to differentiate into coronary endothelial cells
and form coronary arteries. We used the Tnnt2 promoter-Cre
(Tnnt2Cre) (Chen et al., 2006; Jiao et al., 2003) and Vegf-af/f
mice (Gerber et al., 1999) to disrupt Vegf-a in the myocardium
(data not shown). Whole-mount or sectional Pecam1 staining
of E12.5 Tnnt2Cre;Vegf-a+/+ (control) and Tnnt2Cre;Vegf-af/f
(Vegf-a-null) hearts showed that angiogenic sprouts or coronary
plexuses were present in the peritruncal area or ventricular
septum of control (Figures 5A–5D) but not Vegf-a-null hearts
(Figures 5E–5H). Thus, myocardial Vegf-a is necessary for coro-
nary plexus formation.
From E12.5 to E13.5 when coronary plexuses had developed
into a well-organized intramyocardial endothelial network in
control hearts (Figures S6A and S6C), the angiogenic defect
persisted in all Vegf-a-null hearts leading to myocardial necrosis
(Figures S6B and S6D). By E14.5, when control hearts developed
intramyocardial coronary arteries and subepicardial veins with
distinct patterns (Figures 5I–5K), Vegf-a-null hearts had only
a few immature myocardial coronary arteries and developed
dilated subepicardial veins (Figures 5L–5N). Quantitative anal-
ysis confirmed an 88% reduction in the number of Pecam1+
intramyocardial endothelial cells in E14.5 Vegf-a-null hearts,
but only a 37% decrease in the subepicardial endothelial cells
(Figure S5E). These findings indicated that myocardial Vegf-a
triggers coronary angiogenesis and is required for arterial forma-
tion. The fact that coronary veins formed indicated that they
have an embryonic origin independent of myocardial Vegf-a,
although the vein defect might be a consequence of myocardial
Vegf-a deficiency and/or they might be secondary to the arterial
defect.1090 Cell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc.Vegf-a-null hearts also exhibited cardiac phenotypes, includ-
ing thin ventricular walls, necrotic septa, cardiac hemorrhages
(Figures S6G and S6I), and ruptured septa at E15.5 (Figure S6K).
All Vegf-a-null embryos were runted and died after E15.5
(Table S4). To rule out early myocardial defects that might affect
coronary angiogenesis, we examined myocardial function and
structure but found no myocardial apoptosis, abnormal cardiac
gene expression, and alterations in the ultrastructure of sarco-
meres, mitochondria, or Golgi apparatus in E11.5–E12.5 Vegf-
a-null hearts (data not shown). These results suggest that the
cardiac phenotypes are a result of the vascular defects.
Endocardial Vegfr-2 Is Required for Coronary
Angiogenesis and Artery Formation
Vegfr-2 is a major Vegf receptor required for vessel formation
during development (Shalaby et al., 1995). We thus investigated
if Vegfr-2 could transduce Vegf-a signals to trigger coronary
angiogenesis by Nfatc1+ endocardial cells. We used Nfatc1Cre
and Vegfr-2f/f (Haigh et al., 2003) to remove Vegfr-2 in the endo-
cardium. Vegfr-2 antibody staining of E10.5 Vegfr-2+/+;Nfatc1Cre
(control) and Vegfr-2f/f;Nfatc1Cre embryos (Vegfr-2-null) showed
that the deletion was restricted to the endocardium (Figure S7, A
versus A0), whereas Vegfr-2 expression in the vasculature
outside the heart was not affected (Figures S7B–S7E versus
S7B0–S7E0). Similar to E12.5, Vegf-a-null embryos, E12.5
Vegfr-2-null embryos did not develop coronary plexuses in the
peritruncal/coronary sulcus area or ventricular septum (Figures
6A and 6B versus 6C and 6D). The early angiogenic defect
resulted in severely diminished or no coronary arteries in all
E14.5 Vegfr-2-null embryos (Figure 6E versus 6H). In contrast,
coronary veins developed in these embryos (Figure 6F versus
6I). The arterial specific defect was consistent with Vegfr-2
deletion in the Nfatc1+ endocardial precursors, as Vegfr-2 ex-
pression in the endothelium of coronary veins was not affected
(Figure 6G versus 6J).
Like Vegf-a-null embryos, all Vegfr-2-null embryos developed
cardiac hemorrhages at E14.5–E16.5 (Figures S7F and S7H
versus SG and SI), they were runted thereafter and died in utero
(Table S5). Quantitative analysis of immunostaining confirmed
a 74% reduction in the number of Pecam1+ intramyocardial
endothelial cells in E14.5 Vegfr-2-null hearts and only a 24%
decrease in subepicardial endothelial cells (Figures S7J–S7N).
These results demonstrate that Vegfr-2 function is necessary
for differentiation of endocardial cells into endothelial cells to
form coronary arteries.
To track the fate of Vegfr-2-null endocardial cells during coro-
nary angiogenesis, we generated Nfatc1Cre;Vegfr-2f/f;R26fslz and
Nfatc1Cre;Vegfr-2f/f;RCEfsEGFP mice to simultaneously delete
Vegfr-2 and activate reporter gene expression in endocardial
cells. We found that the b-gal+ descendants of Vegfr-2-null
endocardial cells failed to generate intramyocardial coronary
arteries in Nfatc1Cre;Vegfr-2f/f;R26fslz embryos (Figures 6K and
6L versus 6M and 6N). Consistently, coronary angiogenesis
assays with ventricles of E11.5 Nfatc1Cre;Vegfr-2f/f;RCEfsEGFP
embryos showed that EGFP+ Vegfr-2-null endocardial cells
could not respond to Vegf120, and they failed to migrate, sprout,
and form endothelial networks (Figures S7P and S7S versus
S7Q and S7T), which was confirmed by quantitative analysis
Figure 5. Disruption of Vegf-a in the Myocardium Reveals that Myocardial Vegf-a Is Required for Coronary Angiogenesis and Artery
Formation
(A–D) Pictures of E12.5 Tnnt2Cre;Vegf-a+/+ (Control) heart stained with Pecam1 antibodies exhibit coronary plexuses (arrows) in the peritruncal region and
interventricular septum (ivs). Arrowheads indicate the branching endothelial tubes. Dashed lines separate the Pecam1+ vessels in the septum from the Pecam1+
trabeculae.
(E–H) Pictures of E12.5 Tnnt2Cre;Vegf-af/f (Vegf-a-null) heart show no plexus formation in the peritruncal and septal myocardium.
(I–K) Pictures of E14.5 control heart show the Pecam1+ coronary arteries (ca, arrows) and subepicardial vessels (arrowheads).
(L–N) Pictures of E14.5 Vegf-a-null heart show less and immaturely formed coronary arteries (arrows) but numerous and dilated subepicardial vessels
(arrowheads). The null heart also has necrotic peritruncal and septal myocardium (L, arrows).
Scale bars for (I) and (L), 100 mm; for all other panels, 20 mm. See also Figure S6 and Table S4.(Figures S7U and S7V). Thus, these results again indicated that
the initial coronary arteries arise from the Nfatc1+ precursors in
the endocardium and that Vegf signaling is important for this
process.
Taken together, the data from the studies of Vegf-a and Vegfr-
2-null hearts demonstrate that myocardially produced Vegf-aCsignals through endocardial Vegfr-2 to stimulate ventricular
endocardial cells to undergo angiogenesis that generates coro-
nary arteries. They provide a fifth, independently derived line of
functional evidence that endocardial cells are the progenitors
of coronary arteries, whereas the endothelium of coronary veins
has a different origin.ell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc. 1091
Figure 6. Disruption of Vegfr-2 in the Endocardium Shows that Endocardial Vegfr-2 Is Required for Coronary Angiogenesis and Artery
Formation by Endocardial Cells
(A and B) E12.5Nfatc1Cre;Vegfr-2+/+ (Control) heart sections stained with Pecam1 antibodies show coronary endothelial tubes in the myocardium of the coronary
sulcus (cs) (A, inset) and interventricular septum (B, arrowheads).
(C and D) E12.5 Nfatc1Cre;Vegfr-2f/f (Vegfr-2-null) heart sections stained with Pecam1 antibodies show no coronary endothelial tubes in the coronary sulcus
(C, inset) and interventricular septum (D). Dashed lines separate the septum from the Pecam1+ endocardium of trabeculae.
(E–G) E14.5 control heart sections show that mature coronary arteries are positive for vWF staining (E, arrows), and subepicardial coronary veins (cv) are positive
for Ephb4 staining (F, arrows). Vegfr-2 proteins are present in arteries (G, arrowheads) and veins (G, arrows).
(H–J) E14.5 Vegfr-2-null heart sections show no vWF+ coronary arteries in the myocardium (H), but presence of Ephb4+ subepicardial coronary veins (I, arrows).
Vegfr-2 proteins are only present in the coronary veins (J, arrows).
(K and L) X-gal-stained E13.5 Nfatc1Cre;Vegfr-2+/+;R26fslz (Control) heart show that the b-gal+ descendants of Nfatc1+ endocardial cells generate the coronary
vessels in the ventricular wall (arrowheads). Dashed lines distinguish the b-gal+ coronary plexuses in the compact wall from the b-gal+ endocardium of
trabeculae.
(M and N) X-gal-stained E13.5 Nfatc1Cre;Vegfr-2f/f;R26fslz (Vegfr-2-null) heart show no b-gal+ coronary plexuses derived from endocardial cells in the
ventricular wall.
Scale bars in (A) and (C), 100 mm; for all other panels, 20 mm. See also Figures S2 and S7 and Table S5.
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Figure 7. WorkingModel of Coronary Artery
Formation by Endocardial Cells
(A) Diagram shows an ontogenic role for endo-
cardial cells in generation of the coronary arteries.
Between E11.5 and E13.5 of mouse embryogen-
esis, myocardial proliferation generates a Vegf-a
gradient across the thickening ventricular wall,
possibly regulated by a reverse gradient of
myocardial O2 content. At the same time, some
ventricular endocardial cells turn off nuclear
Nfatc1 expression (purple nuclei). The Vegf-a
gradient induces these Nfatc1- endocardial cells
(white nuclei) to invade the myocardium and
proliferate into coronary plexuses by angiogenesis
via their expression of Vegfr-2. The plexuses then
develop into coronary arteries.
(B) Knockout of Vegf-a in the myocardium or
Vegfr-2 in the endocardium prevents coronary
angiogenesis and artery formation, but does not
block coronary vein formation, suggesting that
coronary veins arise from nonendocardial origins,
independent of myocardial Vegf-a to endocardial
Vegfr-2 signaling.DISCUSSION
These studies demonstrated that the endocardium is a major
source of endothelial cells of the coronary vasculature. The
endocardium generates the precursor cells that form coronary
plexuses and develop into endothelial cells of coronary arteries,
arterioles, and capillaries. Such angiogenic functions of endo-
cardial cells appear evolutionarily conserved, as revealed in
transplantation studies in which avian endocardial cells are
capable of generating coronary arterial network.
Our results show that ventricular endocardial cells are not
terminally differentiated but instead are angiogenic for coronary
arteries. The angiogenic sprouting and migration of endocardial
cells into the myocardium is induced by myocardial Vegf-a to
endocardial Vegfr-2 signaling. This is consistent with previous
morphological analysis suggesting that the earliest vessels
develop when encasing endocardial cells penetrate the myocar-
dium and proliferate into an interconnected coronary networkCell 151, 1083–1096, No(Vira´gh and Challice, 1981). In contrast
to the requirement for myocardial Vegf-a
to endocardial Vegfr2 signaling, neither
endocardial deletion of Vegf-a nor proe-
picardial/epicardial deletion of Vegfr-2
blocked intramyocardial coronary angio-
genesis (Z.Z. and B.Z., unpublished
data).
A hypoxia-dependent Vegf-a concen-
tration gradient exists in the myocardium
of the developing heart (Wikenheiser
et al., 2006), and our results indicate
that this gradient provides a cue through
Vegfr-2 in the endocardium to trigger
migration of angiogenic precursor cells
from the endocardium into the myocar-dium (Figure 7A). Once in the myocardium, these cells predom-
inantly differentiate into arterial endothelial cells and populate
intramyocardial arteries, arterioles, and capillaries.
Our analysis showed that Nfatc1 transcription occurs in
the endocardium, but not in the descendant endothelial
cells of coronary vessels. Thus, although the Nfatc1 promoter
is first active in the endocardial cells, it is then shut off as
those cells develop into endothelial cells of the coronary
plexuses. Previous studies have found that spatiotemporally
regulated Nfatc1 expression maintains progenitor cell status
and that its downregulation promotes the differentiation of
progenitor cells in the developing heart valves (Wu et al.,
2011) or hair follicles (Horsley et al., 2008). Whether Nfatc1
expression in ventricular endocardial cells maintains their
progenitor status and/or primes them for later angiogenesis,
and whether scheduled Nfatc1 shut down has a role in coro-
nary angiogenesis are some of important questions currently
under investigation.vember 21, 2012 ª2012 Elsevier Inc. 1093
Though the endocardium is the source of most arterial endo-
thelial cells, the endocardium provides a lesser contribution to
coronary veins. Therefore, the coronary veins have their major
origin outside the endocardium and arise by a different mecha-
nism than the arterial cells. Previous fate mapping using an
inducible Cre (VE-cadherin-CreERT2) (Monvoisin et al., 2006)
showed that the vast majority of the endothelial cells in the
coronary veins arise during development by E9.5 from the sinus
venosus (Red-Horse et al., 2010). A small number of coronary
venous endothelial descendants became coronary artery endo-
thelial cells. Though this led to the conclusion that venous endo-
thelial cells are reprogrammed into arterial endothelial cells, the
fraction of coronary arterial endothelial cells arising from the
sinus venosus was far less than the fraction of coronary venous
endothelial cells. Additionally, a recent study using Scx and
Sema3D Cre lines suggested that a subset of proepicardial/
epicardial cells expressing these genes at E9.5 is able to differ-
entiate into multiple cardiovascular cells, mostly epicardial cells
and/or fibroblasts as well as a small fractions of coronary endo-
thelial and smooth muscle cells (Katz et al., 2012). Our fate-
mapping experiments also showed that a fraction of the sinus
venous endothelial cells are derived from the endocardium, sug-
gesting that endocardial cells may contribute to a minor fraction
of the coronary venous endothelium via the sinus venosus route.
Collectively, these results suggest a mechanism for coronary
vessel development in which the arterial and venous portions
mainly arise from largely distinct embryonic endothelial cell
populations at different anatomical sites and during distinct
developmental windows. Our results showed that around
E11.5, endocardial precursor cells, through Vegfr-2, respond to
Vegf-a signaling from the myocardium and migrate into the
myocardium to form coronary plexuses where they mature into
arteries, arterioles, and capillaries. In contrast, the coronary
venous endothelial cells arisemostly from sinus venous endothe-
lial cells before E9.5 (Red-Horse et al., 2010). We propose that
these processes act in parallel to form the arterial and venous
endothelial populations of the complete coronary vasculature.
Given the importance of coronary artery disease, generation of
coronary arteries by tissue engineering is obviously a highly
desirable goal. Regenerative approaches that recapitulate
normal development may represent an especially attractive
path for development of such therapies. Our results imply that
programmed transient Nfatc1 expression couple with sustained
Vegfr-2-dependent Vegf-a signaling in the progenitor cells of
coronary arterial endotheliummight be useful strategy for regen-
erating coronary arteries.EXPERIMENTAL PROCEDURES
Animals
To generate the Nfatc1Cre mice, an IRES-Cre/PGK-hygromycin cassette was
inserted at the 30 untranslated region of Nfatc1. To disrupt Vegf-a in the
myocardium, Tnnt2Cre mice (Chen et al., 2006; Jiao et al., 2003) were mated
to Vegf-af/f mice (Gerber et al., 1999). Inactivation of Vegfr-2 expression in
the endocardium was achieved by crossing Nfatc1Cre with Vegfr-2f/f mice.
The maintenance of mice and mouse experiments were performed according
to protocols approved by the Institutional Animal Care and Use Committee of
Albert Einstein College of Medicine and Vanderbilt University. Noontime on the
day of detecting vaginal plugs was designated as E0.5.1094 Cell 151, 1083–1096, November 21, 2012 ª2012 Elsevier Inc.Immunostainings and RNA In Situ Hybridization
Primary and secondary antibodies used in this study are listed in Table S1. For
immunostainings, mouse embryos from E9.5 to E12.5 or hearts from E13.5 to
E16.5 were fixed in 4% paraformaldehyde (PFA). A 15%–30% sucrose
gradient was applied to those for frozen sections. Immunohistochemistry
was carried out using the ABC-HRP or ABC-AKmethod (Vector Laboratories).
Fluorescent avidin kit (Vector Laboratories) was used for immunofluorescence
visualization. Whole-mount or section RNA in situ hybridization was performed
to detect Nfatc1 or Cre transcripts in E9.5–E15.5 embryos or hearts using
probes for Nfatc1 or Cre mRNA.
Whole-Mount X-Gal Staining
Embryos from E9.5 to E12.5 or hearts isolated at E13.5 to E14.5 were fixed in
4% PFA on ice for 30 min to 2 hr depending on the developmental stage,
washed in PBS, and then stained with freshly prepared X-gal solution for
2 hr at 37C or overnight at room temperature. The stained samples were
washed by PBS, sectioned, and photographed.
Mouse Ventricular Explant Culture and Coronary Angiogenesis
Assay
Ventricles without the atria and sinus venosus were isolated from E10.5 or
E11.5 embryos, rinsed with PBS to remove circulating cells, and placed in
the Matrigel (growth factor reduced, BD Biosciences) in Nunc 4-well plates.
The Matrigel was prepared by addition of an equal volume of M199 medium
plus 10% fetal bovine serum (FBS) with or without a testing growth factor
including Vegf120, 164, 189, Vegf-c, Vegf-d, Fgf2, or Fgf9 (R&D Systems).
The final concentration of each growth factor was 10 ng/ml. Explants were
cultured for 6 days and angiogenesis by the ventricular endocardial cells
was photographed.
Dye Tracing of Ventricular Endocardial Cells in Ventricular Explant
Cultures
E11.5 hearts were microinjected with the Red Fluorescent CMTPX
(CellTracker, Invitrogen) through their ventricles. After a 2 min incubation on
ice, atria and sinuses were removed. Ventricles were then rinsed with PBS
and placed in the Matrigel with Vegf120. The transmural migration of the
labeled individual endocardial cells and their integration into an endothelial
network were photographed.
Quail-to-Chick Transplantation Assays
Quail ventricular endocardium or ventricular apex without the epicardiumwere
isolated from the Hamburger and Hamilton stages (HH) 15/16 quail embryos,
labeled with carbon particles for visualization, and implanted at the inner
curvature of the atrioventricular junction of HH15/16 chick embryonic hearts.
The implanted chick embryos were incubated at 37C until HH34 or HH42.
The chimerical hearts were isolated and fixed with 3.7% formaldehyde and
cut into anterior and posterior halves through the right ventricle to expose
intramyocardial vasculature, followed by incubation with a mouse monoclonal
anti-QH1 antibody to visualize the contribution of quail endocardial cells to
the developing chick coronary vasculature.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
seven figures, five tables, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.cell.2012.10.023.
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